HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells.

Abstract
The field of tissue engineering entered a new era with the development of human pluripotent stem cells (hPSCs), which are capable of unlimited expansion whilst retaining the potential to differentiate into all mature cell populations. However, these cells harbor significant risks, including tumor formation upon transplantation. One way to mitigate this risk is to develop expandable progenitor cell populations with restricted differentiation potential. Here, we used a cellular microarray technology to identify a defined and optimized culture condition that supports the derivation and propagation of a cell population with mesodermal properties. This cell population, referred to as intermediate mesodermal progenitor (IMP) cells, is capable of unlimited expansion, lacks tumor formation potential, and, upon appropriate stimulation, readily acquires properties of a sub-population of kidney cells. Interestingly, IMP cells fail to differentiate into other mesodermally-derived tissues, including blood and heart, suggesting that these cells are restricted to an intermediate mesodermal fate.
AuthorsNathan Kumar, Jenna Richter, Josh Cutts, Kevin T Bush, Cleber Trujillo, Sanjay K Nigam, Terry Gaasterland, David Brafman, Karl Willert
JournaleLife (Elife) Vol. 4 (Nov 10 2015) ISSN: 2050-084X [Electronic] England
PMID26554899 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Topics
  • Cell Culture Techniques
  • Cell Differentiation
  • Humans
  • Mesoderm
  • Pluripotent Stem Cells (physiology)
  • Stem Cells (physiology)
  • Tissue Engineering

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: